Medicofarma Biotech SA (WSE:MDB)
 0.6120
 +0.0300 (5.15%)
  At close: Oct 27, 2025
Medicofarma Biotech Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
 Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year  | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 | 
|---|---|---|---|---|---|---|---|
Period Ending  | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 | 
Cash & Equivalents     | - | 0.01 | 0.01 | 0.51 | 0.08 | 0.02 | Upgrade   | 
Short-Term Investments     | 0 | - | - | - | - | 0.04 | Upgrade   | 
Cash & Short-Term Investments     | 0 | 0.01 | 0.01 | 0.51 | 0.08 | 0.06 | Upgrade   | 
Cash Growth     | -93.64% | 19.22% | -98.97% | 556.50% | 20.91% | -68.00% | Upgrade   | 
Accounts Receivable     | 0.44 | 0.63 | 0.38 | 0.37 | 1.42 | 0.01 | Upgrade   | 
Other Receivables     | 3.53 | 3.17 | 2.13 | 1.24 | 0.03 | 0.14 | Upgrade   | 
Receivables     | 3.97 | 3.8 | 2.51 | 1.61 | 1.45 | 0.15 | Upgrade   | 
Inventory     | 0 | 0 | 0 | 0.14 | 0.56 | 0.14 | Upgrade   | 
Prepaid Expenses     | - | - | - | - | - | 0.04 | Upgrade   | 
Total Current Assets     | 3.97 | 3.81 | 2.52 | 2.26 | 2.08 | 0.39 | Upgrade   | 
Property, Plant & Equipment     | 9.8 | 10.56 | 12.09 | 12.56 | 12.7 | - | Upgrade   | 
Other Intangible Assets     | 0.07 | 0.1 | 0.15 | 1.54 | 1.98 | - | Upgrade   | 
Long-Term Deferred Tax Assets     | 0.24 | 0.24 | 0.21 | - | - | - | Upgrade   | 
Other Long-Term Assets     | - | - | - | 0.01 | - | 0.01 | Upgrade   | 
Total Assets     | 14.09 | 14.71 | 14.97 | 16.37 | 16.77 | 0.4 | Upgrade   | 
Accounts Payable     | - | 1.29 | 1.19 | 1.34 | 1.47 | 0.2 | Upgrade   | 
Accrued Expenses     | 1.32 | 1.56 | 2.26 | 1.11 | 0.44 | - | Upgrade   | 
Short-Term Debt     | - | 0 | 0 | - | - | 0.39 | Upgrade   | 
Current Income Taxes Payable     | - | 1.5 | 0.53 | 0.14 | 0.06 | 0.04 | Upgrade   | 
Other Current Liabilities     | 3.37 | 0.13 | 0.04 | 0.69 | 0.12 | - | Upgrade   | 
Total Current Liabilities     | 4.69 | 4.49 | 4.02 | 3.28 | 2.08 | 0.62 | Upgrade   | 
Long-Term Debt     | 3.14 | 2.53 | 1.39 | - | - | - | Upgrade   | 
Other Long-Term Liabilities     | 0.77 | 0.82 | 0.38 | 0.48 | 0.48 | - | Upgrade   | 
Total Liabilities     | 8.59 | 7.84 | 5.8 | 3.76 | 2.56 | 0.62 | Upgrade   | 
Common Stock     | 6.8 | 6.8 | 6.8 | 6.8 | 6.8 | 0.68 | Upgrade   | 
Additional Paid-In Capital     | 8.95 | 8.95 | 8.95 | 8.95 | 8.95 | 0.42 | Upgrade   | 
Retained Earnings     | -10.25 | -8.87 | -6.57 | -3.13 | -1.54 | -1.33 | Upgrade   | 
Shareholders' Equity     | 5.49 | 6.87 | 9.18 | 12.61 | 14.2 | -0.23 | Upgrade   | 
Total Liabilities & Equity     | 14.09 | 14.71 | 14.97 | 16.37 | 16.77 | 0.4 | Upgrade   | 
Total Debt     | 3.14 | 2.53 | 1.39 | - | - | 0.39 | Upgrade   | 
Net Cash (Debt)     | -3.13 | -2.53 | -1.39 | 0.51 | 0.08 | -0.32 | Upgrade   | 
Net Cash Growth     | - | - | - | 556.50% | - | - | Upgrade   | 
Net Cash Per Share     | -0.05 | -0.04 | -0.02 | 0.01 | 0.00 | -0.05 | Upgrade   | 
Filing Date Shares Outstanding     | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | 6.78 | Upgrade   | 
Total Common Shares Outstanding     | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | 6.78 | Upgrade   | 
Working Capital     | -0.71 | -0.68 | -1.5 | -1.01 | -0 | -0.24 | Upgrade   | 
Book Value Per Share     | 0.08 | 0.10 | 0.13 | 0.19 | 0.21 | -0.03 | Upgrade   | 
Tangible Book Value     | 5.42 | 6.78 | 9.02 | 11.08 | 12.22 | -0.23 | Upgrade   | 
Tangible Book Value Per Share     | 0.08 | 0.10 | 0.13 | 0.16 | 0.18 | -0.03 | Upgrade   | 
Land     | - | 0.52 | 0.52 | 0.52 | 0.52 | - | Upgrade   | 
Buildings     | - | 5.06 | 5.06 | 5.06 | 5.06 | - | Upgrade   | 
Machinery     | - | 9.01 | 9.01 | 8.11 | 7.34 | - | Upgrade   | 
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.